Packaged Foods · Consumer Defensive
CEO
Kezar Life Sciences, Inc.
Equibles does not estimate personal net worth.
Get an email with a short summary when Hain Celestial Group Inc publishes a filing, an earnings call transcript or a press release.
Get HAIN alertsMark Schiller is recorded as CEO at Hain Celestial Group Inc (HAIN). The proxy statement of Kezar Life Sciences, Inc. reports total compensation of $868,378 for Mark Schiller in fiscal 2024, including a base salary of $451,000. Disclosed compensation is on record for 3 fiscal years. Mark Schiller has spoken on 12 earnings calls across 1 company, most recently for Hain Celestial Group Inc on November 8, 2022. Hain Celestial Group Inc is classified in the Packaged Foods industry within the Consumer Defensive sector. Kezar Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hain Celestial Group Inc includes Alison E. Lewis (CEO and Board Member), Wendy P. Davidson (CEO and Board Member), Jeryl Wolfe (CFO) and 7 others.
“On today's call, I'll give you an overview of our Q1 performance and outlook for the balance of the year. We're pleased to report that we exceeded our constant currency margin and EBITDA guidance in Q1 and showed material sequential improvement.”
“On today's call, Chris and I will give some color on the Q3 performance, our Q4 outlook, and what we’re doing to enable the Hain 3.0 strategy that we discussed on Investor Day last September.”
“On today's call, I'll give some color on our Q2 performance and balance of year forecast as well as progress against the Hain 3.0 strategy we laid out on Investor Day.”
“Let me start by thanking our 3,000 employees for their continued hard work and excellent performance in the face of many macro challenges. We've kept one another informed and worked collaboratively with urgency to deliver continued strong results.”
“On today's call, I'll give some color on our fourth quarter results and provide details on the fiscal 2022 plan.”
Kezar Life Sciences, Inc.
Proxy statement
Start not stated–present
Last confirmed April 25, 2025
Packaged Foods · Consumer Defensive
CEO
Kezar Life Sciences, Inc.
Biotechnology · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kezar Life Sciences, Inc. | Chief Legal Officer | $451,000 | $868,378 |
| 2020 | Hain Celestial Group Inc (HAIN) | President and Chief Executive Officer | $996,154 | $5,184,257 |
| 2019 | Hain Celestial Group Inc (HAIN) | President and Chief Executive Officer | $571,154 | $5,873,652 |